Skip to main content

Table 1 Clinicopathological variables of 556 patients with unilateral PRCC treated with partial or radical nephrectomy (development cohort)

From: The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort

Variable

Category

 

Age, years

Median

63

IQR

54–70

Gender, n (%)

Female

145 (26.1)

Male

411 (73.9)

T stage, n (%)

pT1

370 (66.5)

pT2

61 (11.0)

pT3

123 (22.1)

pT4

2 (0.4)

N stage, n (%)

pNx/pN0

537 (96.6)

pN1

19 (3.4)

Nuclear grade, n (%)

1 or 2

381 (68.5)

3 or 4

175 (31.5)

Tumour size, n (%)

4.0 cm or less

285 (51.3)

4.1 to 10.0 cm

219 (39.4)

10.1 cm or greater

52 (9.4)

Median

4.0

IQR

2.7–6.3

Surgical margin, n (%)

Negative

525 (94.4)

Positive

31 (5.6)

Venous tumour thrombus, n (%)

None

524 (94.2)

Renal vein

15 (2.7)

Cava

17 (3.1)

Perinephric/sinus fat invasion, no venous tumour thrombus, n (%)

93 (16.7)

Papillary type, n (%)

Type 1

227 (46.0)

Type 2

266 (54.0)

Tumour necrosis, n (%)

254 (45.7)

Sarcomatoid features, n (%)

11 (2.0)

UISS, n (%)

Low/intermediate risk

335 (60.3)

Intermediate high risk

141 (25.4)

Very high risk

80 (14.4)

2018 Leibovich group, n (%)

Low (group 1)

322 (57.9)

Intermediate (group 2)

102 (18.3)

High (group 3)

132 (23.7)

TNM group, n (%)

I

369 (66.4)

II

60 (10.8)

III

125 (22.5)

IV

2 (0.4)